Loading clinical trials...
Loading clinical trials...
Phase 3 Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:
Conditions
Interventions
Dichloroacetate (DCA)
Placebo
+1 more
Locations
10
United States
Children's Hospital of Orange County
Orange, California, United States
Stanford University
Stanford, California, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
University of Florida
Gainesville, Florida, United States
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Start Date
July 14, 2020
Primary Completion Date
August 27, 2025
Completion Date
August 27, 2025
Last Updated
May 4, 2025
Lead Sponsor
Saol Therapeutics Inc
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions